HomeTrading IdeasGold Slips Amid Uncertainty...

Gold Slips Amid Uncertainty Over Fed Rate Cuts and Weak US Dollar

Gold Is Under Pressure Due To Uncertainty About Fed Interest Rate Path

Gold prices () fell by 0.12% on Thursday despite a weakening (USD) as investors continued to recalibrate expectations around the policy path. A weaker US dollar typically supports gold, but the market appeared to focus instead on mixed signals from economic data and central bank commentary. Investors remain cautious, awaiting clearer confirmation of the Fed’s rate path amid growing political and macroeconomic uncertainty.

Speculation is mounting that US President Donald Trump may announce his nominee for the Fed Chair role in September or October. Markets anticipate a candidate who is inclined towards a more accommodative monetary policy. Meanwhile, Fed Chair Jerome Powell indicated that the absence of new tariffs would contribute to disinflation, potentially opening the door to multiple rate cuts if aggressive trade measures are avoided. His comments reinforced the notion that the Fed remains flexible and data-dependent but fell short of committing to immediate easing.

Recent US economic data painted a mixed picture. A revised reading showed the economy contracted by 0.5% in Q1, fuelling dovish expectations. However, this was partially offset by a drop in towards a five-week low and a surprising surge in —the strongest in over a decade—suggesting underlying resilience.

XAU/USD continued declining during the Asian and early European trading sessions. Market attention is now on the (PCE) Price Index report due at 12:30 p.m. UTC today. The data could provide further insights into how the Fed plans its monetary policy path. Higher-than-expected figures will likely deepen downward pressure on XAU/USD, while weaker numbers could give gold bullish momentum.

Euro Rises on Dovish Fed Rhetoric

The euro () continued to rise on Thursday, reaching its highest point since September 2021, as markets increasingly priced in a more dovish monetary policy stance from the Federal Reserve.

Speculation over US President Donald Trump’s potential nomination of a new Fed Chair by September or October added pressure to the US dollar (USD), as investors anticipated a shift towards looser financial conditions. The possibility of a ’shadow’ leadership dynamic at the central bank raised questions about the future direction of US monetary policy.

Fed Chair Jerome Powell adopted a notably dovish tone in his recent congressional testimony, weighing further on the US dollar. He emphasised that in the absence of tariff-induced , the Fed would likely have continued its cutting rates—signalling that the central bank remains open to easing if economic conditions permit. His comments reinforced expectations for policy flexibility and supported market projections for significant rate cuts in the coming months. Broader risk sentiment improved after the White House downplayed the urgency of looming tariff deadlines, helping to ease fears of a prolonged trade conflict and reducing safe-haven demand for the US dollar. These factors continue to shape a stronger outlook for the euro.

Today, traders are watching for the release of the Personal Consumption Expenditure () Price Index at 12:30 p.m. UTC. The data is the Fed’s preferred measure of inflation and may offer additional clues on the timing and scale of potential rate cuts. If the figures exceed forecasts, EUR/USD may correct sharply downwards. Otherwise, the bullish trend is likely to continue.

Bitcoin Rises Despite Broader Market Uncertainty

(BTC/USD) traded near the $108,000 mark on Thursday as investors assessed the evolving macroeconomic and regulatory landscape.

A key driver of sentiment remains the Federal Reserve’s (Fed) increasingly dovish stance. Fed Chair Jerome Powell reiterated in recent testimony that rate cuts are possible if inflation continues to moderate. This shift has lowered yields on traditional safe-haven assets and increased demand for alternative assets like Bitcoin. Furthermore, the US Dollar Index is approaching multi-year lows, with Bitcoin benefiting from its inverse correlation to the greenback and attracting additional interest from institutional investors.

Fundamentally, Bitcoin’s network health remains robust, with the hash rate hovering near all-time highs and transaction fees stabilising at sustainable levels after April’s halving. Miner profitability has improved due to rising prices and greater operational efficiencies, supporting the long-term security of the blockchain. Additionally, on-chain data indicates increased holding behaviour among long-term wallets, suggesting sustained conviction among core market participants. While short-term catalysts may depend on macroeconomic data and central bank signals, Bitcoin’s broader adoption trajectory and growing integration into global portfolios underpin a bullish long-term thesis.

BTC/USD rose during the Asian and early European trading sessions. Today, traders will focus on the release of the Personal Consumption Expenditures () Price Index at 12:30 p.m. UTC. The report may spur volatility and shed light on potential shifts in the US monetary policy. Key BTC/USD levels to watch are support at $106,000 and resistance at $108,360.

Most Popular

More from Author

The Bull Market Is Alive and Well

The bull market is alive and well, even amid widespread talk...

Why Is Jasper Therapeutics Stock Falling On Monday? – Jasper Therapeutics (NASDAQ:JSPR)

Jasper Therapeutics, Inc. JSPR stock is experiencing a steep decline on...

Stocks Wobble as Trump Resurrects Tariff Threats Ahead of July 9 Deadline

Market participants were expecting an upbeat start to the week on...

CAD/JPY Ready to Continue Rising Ahead of Employment Change and Unemployment Rate

For three months since April, the currency has shown strength...

Read Now

The Bull Market Is Alive and Well

The bull market is alive and well, even amid widespread talk of the “death of U.S. exceptionalism.” Early 2025 saw a sharp shift in investor sentiment. Concerns over erratic trade policy, soaring debt, and weakening pressure challenged America’s long-standing market dominance. Markets fell sharply in April...

Why Is Jasper Therapeutics Stock Falling On Monday? – Jasper Therapeutics (NASDAQ:JSPR)

Jasper Therapeutics, Inc. JSPR stock is experiencing a steep decline on Monday, plummeting by nearly 55%. This significant drop is accompanied by an exceptionally high trading volume of 9.9 million shares, vastly exceeding its average daily volume of 251.9K, according to data from Benzinga Pro.What Happened?The company...

Stocks Wobble as Trump Resurrects Tariff Threats Ahead of July 9 Deadline

Market participants were expecting an upbeat start to the week on the hope that trade deals might finally be announced as the Trump administration deadline of July 9 approaches. However, President Trump adopted a confrontational stance once more by announcing that the US will begin issuing tariff...

CAD/JPY Ready to Continue Rising Ahead of Employment Change and Unemployment Rate

For three months since April, the currency has shown strength against the . although at the moment the price still cannot break the small resistance area on the H4 timeframe. but it is expected that the fundamental impulses can move the market more significantlyFigure 1. CAD/JPY...

What’s Going On With Hims & Hers Health Stock On Monday? – Hims & Hers Health (NYSE:HIMS)

Hims & Hers Health, Inc. HIMS is currently experiencing a decline in its stock price, trading lower on Monday. The company’s stock has plummeted approximately 18% over the past month, reflecting recent challenges.A significant development contributing to this decline occurred in June 2025, when Novo Nordisk A/S...

Why Is Cogent Biosciences Stock Trading Higher On Monday? – Cogent Biosciences (NASDAQ:COGT)

Cogent Biosciences, Inc.‘s COGT bezuclastinib showed meaningful clinical benefit for patients with non-advanced systemic mastocytosis, a rare and debilitating immune disorder. With statistically significant improvements across all endpoints—including symptom reduction and biomarkers of mast cell activity—the data support the company's plan to file for Food and Drug Administration...

3 Bullish Setups to Watch in July Amid Seasonal Tailwinds

As the second half of the year begins, several bullish setups are emerging—each supported by seasonal patterns and historical data. is approaching multi-year highs following a strong June, while technical signals in the broader market and semiconductor sector point to continued momentum. Meanwhile, recent policy developments may...

The Energy Report: Listen to What OPEC Says

prices are shaking off a larger-than-expected OPEC production increase as the precious metals get hit by a ton of bricks after President Trump posted about new tariffs on BRIC Nations on his Truth Social account. Yet despite the talk about OPEC wanting to maintain its market share,...

Why Is KalVista Pharmaceuticals Stock Soaring On Monday? – KalVista Pharma (NASDAQ:KALV)

The U.S. Food and Drug Administration (FDA) on Monday approved KalVista Pharmaceuticals Inc.’s KALV Ekterly (sebetralstat) for acute attacks of hereditary angioedema (HAE) in adult and pediatric patients aged 12 years and older.Ekterly is the first and only oral on-demand treatment for HAE. HAE is characterized by recurrent...

Dow Jones Forecast: Political Tensions and Tariff Risks Weigh on Outlook

US futures are rising on Monday after the extended holiday weekend. Uncertainty surrounding U.S. trade tariff policies are keeping investors cautious, whilst Tesla (NASDAQ:) is taking a hit after Musk announced plans to launch a political party.US Futures 0.78% at 44839 0.7% at 6266 0.53% at 23977In...

Why Is Apogee Therapeutics Stock Soaring On Monday? – Apogee Therapeutics (NASDAQ:APGE)

Apogee Therapeutics Inc. APGE stock is experiencing a significant surge, trading almost 29% higher in premarket on Monday.This substantial increase in stock price follows the release of positive 16-week data from Part A of the Phase 2 APEX clinical trial of APG777, an anti-IL-13 antibody, for moderate-to-severe...

EUR/USD Slips as Trade Talks Stall and Retail Sales Disappoint

falls with trade talks in focus and following weak retail sales. Oil slips after OPEC+ increases output by more than expected.EUR/USD Falls With Trade Talks in Focus and After Weak Retail SalesThe EU and the US are nearing a framework agreement Eurozone retail sales fell -0.7% MoM EUR/USD...